Specialist global insurer Hiscox has licensed Praedicat’s AI-driven liability cat risk modeling platforms CoMeta and Oortfolio for use within its London Market casualty business.
Praedicat’s AI technology is designed to mine peer-reviewed published scientific literature to extract signals of emerging risk, map these risks to commercial activity, and quantify losses that could result from mass tort litigation.
Hiscox says it is building out its existing approach to exposure management with Praedicat, which will contribute to its underwriting strategy by helping to identify areas of opportunity and increase portfolio diversification.
Hiscox will also use Praedicat’s Portfolio Underwriting and Aggregation Monitoring workflows to identify emerging risks, and to evaluate and benchmark individual account risk by relying upon the 40,000 individually profiled companies and their associated loss estimates in Praedicat’s database.
Using Praedicat’s probabilistic loss model results, Hiscox hopes to be able to assess the impact of latent liability exposures to Hiscox’s book of business, while stress testing its portfolio against Praedicat’s library of 88 latent liability RDS and XDS scenarios.
“Praedicat’s CoMeta and Oortfolio products provide insurers with the ability to manage their casualty risks more effectively and forward-plan their portfolios against emerging risks,” said Grant Dewar, Senior Vice President, Global Head of Sales at Praedicat.
“We are delighted that Hiscox has chosen to partner with Praedicat to manage its London Market casualty business.”
“It is a privilege to gain the acceptance of Hiscox for casualty risk management,” said Bob Reville, Praedicat co-founder and CEO.
“I’ve admired Hiscox’s innovative products and its market-leading exposure management and underwriting expertise for many years. We are honored that as they grow their casualty business, they have turned to Praedicat to partner in managing emerging risks.”
Craig Knightly, Casualty Division Director at Hiscox London Market, added, “Praedicat provides Hiscox with the ability to strategically assess our existing portfolio to manage our exposure while also being able to stress test the book against Praedicat’s liability cat scenarios, such as opioids, the COVID-19 pandemic, and PFAS, to name a few.
“We are always looking to gain more insight into the risks our clients are exposed to and Praedicat will undoubtedly be a valuable additional tool in our day-to-day underwriting.”